Attenuation of cardiovascular stress response to endotracheal intubation by the use of remifentanil in patients undergoing Cesarean delivery

Journal of Anesthesia

Volumn 30, Issue 2, 2016, Pages 274-283

  Kutlesic, Marija S ^a   Kutlesic, Ranko M ^a,b   Mostic Ilic, Tatjana ^c,d  

^a University Clinical Centre of Nis   (Serbia)

^b UNIVERSITY OF NI   (Serbia)

^c Institute of Gynecology and Obstetrics   (Serbia)

^d UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

Anesthesia; Endotracheal; Intubation; Obstetrical; Remifentanil

Indexed keywords

REMIFENTANIL; PIPERIDINE DERIVATIVE;

ANESTHESIA INDUCTION; CARDIOVASCULAR FUNCTION; CESAREAN SECTION; DOSE RESPONSE; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG HALF LIFE; DRUG MECHANISM; ENDOTRACHEAL INTUBATION; HEALTH CARE PERSONNEL; HUMAN; MATERNAL STRESS; OPERATING ROOM; RESPIRATION DEPRESSION; RESUSCITATION; REVIEW; CARDIOVASCULAR SYSTEM; FEMALE; GENERAL ANESTHESIA; INTRAOPERATIVE AWARENESS; LARYNGOSCOPY; METABOLISM; PREGNANCY; PROCEDURES;

ANESTHESIA, GENERAL; CARDIOVASCULAR SYSTEM; CESAREAN SECTION; FEMALE; HUMANS; INTRAOPERATIVE AWARENESS; INTUBATION, INTRATRACHEAL; LARYNGOSCOPY; PIPERIDINES; PREGNANCY;

EID: 84951930032     PISSN: 09138668     EISSN: 14388359     Source Type: Journal    
DOI: 10.1007/s00540-015-2118-5     Document Type: Review

References (99)

1. Lyons G, Akerman N. Problems with general anaesthesia for Caesarean section. Minerva Anesthesiol. 2005;71:27–38.
2. Rollins M, Lucero J. Overview of anesthetic considerations for Caesarean delivery. Br Med Bull. 2012;101:105–25.
3. Jadon A. Complications of regional and general anaesthesia in obstetrics practice. Indian J Anesth. 2010;54:415–20.
4. Wong CA. General anesthesia is unacceptable for elective cesarean section. Int J Obstet Anesth. 2010;19:209–12.
5. Reynolds F. General anesthesia is unacceptable for elective cesarean section. Int J Obstet Anesth. 2010;19:212–7.
6. Schmidt AP, Auler JOC. Evidence-based obstetrics anesthesia. An update on anesthesia for Caesarean delivery. In: Salim R, editor. Cesarean delivery. Rijeka: In Tech; 2012. p. 69–92. doi:10.5772/47969.
7. Mostić-Ilić T, Petronijević M, Antonijević V, Ivanković Ž, Mostić D, Kendrišić M. General anesthesia and uteroplacental drug transfer. Serbian J. Anesth. Intensive Therapy. 2013;35: 381–5. http://www.uais.rs/wp-content/uploads/2013/12/SJAIT-vol-35-7-8.pdf.
8. Chohan U, Afshan G, Mone A. Anaesthesia for caesarean section in patients with cardiac disease. J Pak Med Assoc. 2006;56:32–8.
9. Mc Glennan A, Mustafa A. General anaesthesia for Caesarean section. Continuing education in anaesthesia. Crit Care Pain. 2009;9(5):148–51.
10. Brown JPR. Recent developments in anaesthesia for caesarean section in the UK. Update Anaesth. 2008;23:3–7.
11. Robins K, Lyons G. Intraoperative awareness during general anesthesia for Caesarean delivery. Anesth Analg. 2009;109:886–90.
12. Littleford J. Effects on the fetus and newborn of maternal analgesia and anesthesia: a review. Can J Anesth. 2004;51:586–609.
13. Murdoch H, Scrutton M, Laxton CH. Choice of anaesthetic agents for caesarean section: a UK survey of current practice. Int J Obstet Anesth. 2013;22:31–5.
14. Van de Velde M. Remifentanil for obstetric analgesia and anesthesia: a review of the literature. Acta Anaesthesiol Belg. 2005;56:45–9.
15. Khan MF, Samad K, Shamim F, Ullah H. Awareness during anesthesia—an update. Middle East J Anaesthesiol. 2008;19:723–35.
16. Paech MJ, Scott KL, Clavisi O, Chua S, McDonnell N. A prospective study of awareness and recall associated with general anaesthesia for caesarean section. Int J Obstet Anesth. 2009;17:298–303.
17. Pandit JJ, Andrade J, Bogod DG, Hitchman JM, Jonker WR, Lucas N, Mackay JH, Nimmo AF, O’Conor K, O’Sullivan EP, Paul RG, Palmer JH, Plaat F, Radcliffe JJ, Sury MR, Torevell HE, Wang M, Hainsworth J, Cook TM. Royal College of Anaesthetists; Association of Anaesthetists of Great Britain and Ireland. 5th National Audit Project (NAP5) on accidental awareness during general anaesthesia: summary of main findings and risk factors. Br J Anaesth. 2014;113:549–59. doi:10.1093/bja/aeu313.
18. Dünges B, Heid F, Dauster M, Strecker U, Röhrig B, Brambrink AM. Revisited: Haemodynamic instability and endocrine response during endotracheal tube-placement. A prospective, randomized trial using topical lidocaine and a lightwand. Open Anesthesiol J. 2008;2:30–9. doi:10.2174/1874321800802010030.
19. Safavi M, Honarmand A. Attenuation of cardiovascular responses to laryngoscopy and tracheal intubation. Middle East J Anaesthesiol. 2008;19:1349–58.
20. Montazeri K, Kashefi P, Honarmand A, Safavi M, Hirmanpour A. Attenuation of the pressor response to direct laryngoscopy and tracheal intubation: oral clonidine vs. oral gabapentin premedication. J Res Med Sci. 2011;16:377–86.
21. Pournajafian A, Rokhtabnak F, Kholdbarin A, Ghodrati M, Ghavam S. Comparison of remifentanil and fentanyl regarding hemodynamic changes due to endotracheal intubation in preeclamptic parturient candidate for Caesarean delivery. Anesth Pain. 2012;2:90–3.
22. Safavi M, Honarmand A, Azari N. Attenuation of the pressor response to tracheal intubation in severe preeclampsia: relative efficacies of nitroglycerine infusion, sublingual nifedipine and intravenous hydralazine. Anesth Pain. 2011;1:81–9.
23. Hagberg C, Georgi R, Krier C. Complications of managing the airway. Best Pract Res Clin Anaesthesiol. 2005;19:641–59.
24. Khan ZH. Preeclampsia–eclampsia: an insight into the dilemma of treatment by the anesthesiologist. Acta Med Iran. 2011;49:564–74.
25. Hassani V, Movassaghi G, Goodarzi V, Safari S. Comparison of fentanyl and fentanyl plus lidocaine on attenuation of hemodynamic responses to tracheal intubation in controlled hypertensive patients undergoing general anesthesia. Anesth Pain Med. 2013;2:115–8.
26. Kutlesic M, Kutlesic R, Koracevic G. Significance, aetiology and prevention of venous thromboembolism in pregnancy and puerperium. Vojnosanit Pregl. 2014;71:580–7.
27. Lin SY, Hu CJ, Lin HC. Increased risk of stroke in patients who undergo cesarean section delivery: a nationwide population-based study. Am J Obstet Gynecol. 2008;98:391.e1–7.
28. Tang CH, Hung ST, Chu PS. Preeclampsia–eclampsia and the risk for stroke among peripartum in Taiwan. Stroke. 2009;40:1162–8.
29. Huang CJ, Fan YC, Tsai PS. Differential impacts of modes of anesthesia on the risk of stroke among preeclamptic women who undergo Caesarean delivery: a population-based study. Br J Anaesth. 2010;105:818–26.
30. Heesen M, Klohr S, Hofmann T, Rossaint R, Devroe S, Straube S, Van de Velde M. Maternal and foetal effects of remifentanil for general anaesthesia in parturients undergoing caesarean section: a systematic review and meta-analysis. Acta Anaesthesiol Scand. 2013;57:29–36.
31. Hill D. The use of remifentanil in obstetrics. Anesthesiol Clin. 2008;26(1):169–82.
32. Cipolla MJ, Sweet JG, Chan SL. Cerebral vascular adaptation to pregnancy and its role in the neurological complications of eclampsia. J Appl Physiol (1985). 2011;2011(110):329–39.
33. Kutlešić M, Kutlešić R, Ilić D, Koraćević G. PRES as a complication of a moderate preeclampsia: case report and short review of literature. Facta Univ Ser Med Biol. 2014;16:96–9.
34. Kutlesic M, Kutlesic R, Koracevic G. Posterior reversible encephalopathy syndrome in eclamptic patients: neuroradiological manifestation, pathogenesis and management. Med Pregl. 2015;68(1–2):53–8. doi:10.2298/MPNS1502053K.
35. Gin T, Ngan-Kee WD, Siu YK, Stuart JC, Tan PE, Lam KK. Alfentanil given immediately before the induction of anesthesia for elective Cesarean delivery. Anesth Analg. 2000;90:1167–72.
36. Hall AP, Thompson JP, Leslie NAP, Fox AJ, Kumar N, Rowbotham DJ. Comparison of different doses of remifentanil on the cardiovascular response to laryngoscopy and tracheal intubation. Br J Anaesth. 2000;84:100–2.
37. Uysal HY, Tezer E, Turkoglu M, Aslanargun P, Basar H. The effects of dexmedetomidine on hemodynamic responses to tracheal intubation in hypertensive patients. A comparison with esmolol and sufentanil. J Res Med Sci. 2012;17:22–31.
38. Park SJ, Shim YH, Yoo JH, Nam JW, Lee JW. Low-dose remifentanil to modify hemodynamic responses to tracheal intubation: comparison in normotensive and untreated/treated hypertensive Korean patients. Korean J Anesthesiol. 2012;62:135–41.
39. Rueda Fuentes JV, Pinzón Flores CE, Ramirez MV. Anaesthetic management in emergency cesarean section: Systematic literature review of anaesthetic techniques for emergency C-section. Rev Colomb Anestesiol. 2012;40:273–86. doi:10.1016/j.rcae.2012.09.002.
40. Khan FA, Ullah H. Pharmacological agents for preventing morbidity associated with the haemodynamic response to tracheal intubation. Cochrane Database Syst Rev. 2013;7:CD004087. doi:10.1002/14651858.CD004087.pub2.
41. Thompson JP, Hall A, Russel J, Cagney B, Rowbottam DJ. Effect of remifentanil on the haemodynamic response to orotracheal intubation. Br J Anaesth. 1998;80:467–9.
42. Yoo KY, Jeong CW, Park BY, Kim SJ, Jeong ST, Shin MH, Lee J. Effects of remifentanil on cardiovascular and bispectral index responses to endotracheal intubation in severe pre-eclamptic patients undergoing Caesarean delivery under general anaesthesia. Br J Anaesth. 2009;102:812–9. doi:10.1093/bja/aep099.
43. Gebhardt R, Armstrong SL, de Leon-Casasola OA, Chai T, Sparlin JA, Rivers JM, Fernando R. Postoperative multimodal acute pain management: Caesarean and vaginal delivery. In: Suresh M, editor. Shnider and Levinson’s anesthesia for obstetrics. 5th ed. Philadelphia: Lippincott Williams and Wilkins; 2013. p. 182–98.
44. Allen RW, James MFM, Uys PC. Attenuation of the pressor response to tracheal intubation in hypertensive proteinuric pregnant patients by lignocaine, alfentanil and magnesium sulphate. Br J Anaesth. 1991;66:216–23.
45. Bajwa SJS, Kaur J, Singh A, Parmar SS, Singh G, Kulshrestha A, Gupta S, Sharma V, Pande A. Attenuation of pressor response and dose sparing of opioids and anaesthetics with pre-operative dexmedetomidine. Indian J Anaesth. 2012;56:123–8.
46. Ebneshahidi A, Mohseni M. Premedication with oral clonidine decreases intraoperative bleeding and provides hemodynamic stability in cesarean surgery section. Anesth Pain. 2011;1:30–3.
47. Hanoura SE, Saad RH, Singh R. Dexmedetomidine improves intraoperative conditions and quality of postoperative analgesia when added to epidural in elective cesarean section. Egyp J Anaesth. 2014;30:353–7. doi:10.1016/j.egja.2014.03.004.
48. Nair AS, Sriprakash K. Dexmedetomidine in pregnancy: review of literature and possible use. J Obstet Anaesth Crit Care. 2013;3:3–6. doi:10.4103/2249-4472.114253.
49. Yu M, Han C, Jlang X, Wu X, Yu L, Ding Z. Effect and placental transfer of dexmedetomidine during caesarean section under general anaesthesia. Basic Clin Pharmacol Toxicol. 2015;117:204–8.
50. Palanisamy A, Klickovich RJ, Ramsay M, Ouyang DW, Tsen LC. Intravenous dexmedetomidine as an adjunct for labor analgesia and cesarean delivery anesthesia in a parturient with a tethered spinal cord. Int J Obstet Anesth. 2009;18:258–61.
51. Weiner MM, Chow R, Salter BS. A case of fetal bradycardia following dexmedetomidine bolus. J Obstet Anaesth Crit Care. 2014;4:75–7. doi:10.4103/2249-4472.143876.
52. Duan M, Lee J, Bittner EA. Dexmedetomidine for sedation in the parturient with respiratory failure requiring noninvasive ventilation. Respir Care. 2012;57:1967–9.
53. Ali AR, El Gohary M, Salah El-din Ashmawi H, El-Kerdawy HM, Essa HH. Efficacy of preoperative oral gabapentin in attenuation of neuro-endocrine response to laryngoscopy and endotracheal intubation. J Med Sci. 2009;9:24–9. doi:10.3923/jms.2009.24.29.
54. Moore A, Costello J, Wieczorek P, Shah V, Carvalho JC. Gabapentin improves post cesarean delivery pain management, a randomized, placebo controlled trial. Anesth Analg. 2011;112:167–73.
55. Nofal WH, Mahmoud MS, Al Alim AA. Does preoperative gabapentin affects the characteristics of post-dural puncture headache in parturients undergoing cesarean section with spinal anesthesia? Saudi J Anaesth. 2014;8(3):359–63.
56. Yallapragada SV, Vidadhala KS, Vemuri NN, Shaik MS. Effect of esmolol on variation of rate-pressure product due to tracheal intubation—an evaluation using invasive arterial pressure monitoring. IJBAR. 2014;5:443–5. doi:10.7439/ijbar.v5i9.876.
57. Singhal SK, Malhotra N, Kaur K, Dhaiya D. Efficacy of esmolol administration at different time intervals in attenuating hemodynamic response to tracheal intubation. Indian J Med Sci. 2010;64:468–75.
58. Kayhan GE, Gulhas N, Sahin T, Ozgul U, Sanli M, Durmus M, Ersoy MO. Anaesthesia for caesarean delivery in a pregnant with acute type B aortic dissection. Turk J Anaesth Reanim. 2013;41:178–81. doi:10.5152/TJAR.2013.27.
59. Rothmensch HH, Elkayam U, Frishman W. Antiarrhythmic drug therapy during pregnancy. Ann Intern Med. 1983;98:487–97.
60. Gill TE, Mani S, Dessables DR. Anesthetic management of cerebral aneurysm clipping during pregnancy: a case report. AANA J. 1993;61:282–6.
61. Fairley CJ, Clarke JT. Use of esmolol in a parturient with hypertrophic obstructive cardiomyopathy. Br J Anaesth. 1995;75:801–4.
62. Bansal S, Pawar M. Haemodynamic responses to laryngoscopy and intubation in patients with pregnancy-induced hypertension: effect of intravenous esmolol with or without lidocaine. Int J Obstet Anesth. 2002;11:4–8.
63. Bosco FAP, Braz JRC. Beta-blockers in anesthesiology: clinical and pharmacological aspects. Rev Bras Anestesiol. 2001;51:431–47.
64. Malviya PS, Raw BK, Gupta BK. Evaluation of dexmedetomidine for attenuation of haemodynamic response to tracheal intubation in treated hypertensive patients: a comparison with esmolol. Anaesth Update. 2013;16:18–23.
65. Honarmand A, Safavi M, Badiei S, Daftari-Fard N. Different doses of intravenous Magnesium sulfate on cardiovascular changes following the laryngoscopy and tracheal intubation: a double-blind randomized controlled trial. J Res Pharm Pract. 2015;4:79–84.
66. Nooraei N, Dehkordi ME, Radpay B, Teimoorian H, Mohajerani SA. Effects of intravenous magnesium sulfate and lidocaine on hemodynamic variables following direct laryngoscopy and intubation in elective surgery patients. Tanaffos. 2013;12(1):57–63.
67. James MF. Magnesium: an emerging drug in anaesthesia. Br J Anaesth. 2009;103:465–7. doi:10.1093/bja/aep242.
68. Panda NB, Bharti N, Prasad S. Minimal effective dose of magnesium sulfate for attenuation of intubation response in hypertensive patients. J Clin Anesth. 2013;25:92–7. doi:10.1016/j.jclinane.2012.06.016.
69. Do SH. Magnesium: a versatile drug for anesthesiologists. Korean J Anesthesiol. 2013;65:4–8. doi:10.4097/kjae.2013.65.1.4.
70. Lee DH, Kwon IC. Magnesium sulphate has beneficial effects as an adjuvant during general anaesthesia for Caesarean section. Br J Anaesth. 2009;103:861–6.
71. Dean C, Douglas J. Magnesium and the obstetric anaesthetist. Int J Obstet Anesth. 2013;22(1):52–63.
72. Kim SH, Stoicea N, Soghomonyan S, Bergese SD. Intraoperative use of remifentanil and opioid induced hyperalgesia/acute opioid tolerance: systematic review. Front Pharmacol. 2014;5:108. doi:10.3389/fphar.2014.00108.
73. Song YK, Lee C, Seo DH, Park SN, Moon SY, Park CH. Interaction between postoperative shivering and hyperalgesia caused by high-dose remifentanil. Korean J Anesthesiol. 2014;66:44–51. doi:10.4097/kjae.2014.66.1.44.
74. Ibrahim IT, Megalla SA, Khalifa OSM, El Deen HMS. Prophylactic vs. therapeutic magnesium sulfate for shivering during spinal anesthesia. Egypt J Anaesth. 2014;30:31–7. doi:10.1016/j.egja.2013.07.007.
75. Albrecht E, Kirkham KR, Liu SS, Brull R. Peri-operative intravenous administration of magnesium sulphate and postoperative pain: a meta-analysis. Anaesthesia. 2013;68:79–90. doi:10.1111/j.1365-2044.2012.07335.x.
76. Héman L, Linden P. Does magnesium sulfate increase the incidence of postpartum hemorrhage? A systematic review. Open J Obstet Gynecol. 2011;1:168–73. doi:10.4236/ojog.2011.14032.
77. Egan TD, Kern SE, Muir KT, White J. Remifentanil by bolus injection: a safety, pharmacokinetic, pharmacodynamic and age effect investigation in human volunteers. Br J Anaesth. 2004;92:335–43.
78. O’Hare R, McAtamney D, Mirakhur RK, Hughes D, Carabine U. Bolus dose remifentanil for control of haemodynamic response to tracheal intubation during rapid sequence induction of anaesthesia. Br J Anaesth. 1999;82:283–5.
79. Draisci G, Valente A, Suppa E, Frassanito L, Pinto R, Meo F, De Sole P, Bossù E, Zanfini BA. Remifentanil for cesarean section under general anesthesia: effects on maternal stress hormone secretion and neonatal well-being: a randomized trial. Int J Obstet Anesth. 2008;17:130–6. doi:10.1016/j.ijoa.2008.01.002.
80. NganKee WD, Kaw KS, Ma KC, Wong ASY, Lee BB, Floria F. Maternal and neonatal effects of remifentanil at induction of general anesthesia for cesarean delivery. Anesthesiology. 2006;104:14–20.
81. Bédard J, Richardson MG, Wissler RN. General anesthesia with remifentanil for Caesarean section in a parturient with an acoustic neuroma. Can J Anesth. 1999;46:576–80.
82. Glass PS, Gan TJ, Howell S. A review of the pharmacokinetics and pharmacodynamics of remifentanil. Anesth Analg. 1999;89:S7–14.
83. Maguire AM, Kumar N, Parker JL, Rowbotham DJ, Thompson JP. Comparison of effects of remifentanil and alfentanil on cardiovascular response to tracheal intubation in hypertensive patients. Br J Anaesth. 2001;86:90–3.
84. Bi SS, Deng CH, Zhou TY, Guan Z, Li L, Li HQ, Zhang LP, Yang L, Lu W. Remifentanil–sevoflurane interaction models of circulatory response to laryngoscopy and circulatory depression. Br J Anaesth. 2013;110:729–40.
85. Kan RE, Hughes SC, Rosen MA, Kessin C, Preston PG, Lobo EP. Intravenous remifentanil: placental transfer, maternal and neonatal effects. Anesthesiology. 1998;88:1467–74.
86. Van de Velde M, Teunkens A, Kuypers M, Dewinter T, Vandermeersch E. General anaesthesia with target controlled infusion of propofol for planned caesarean section: maternal and neonatal effects of a remifentanil-based technique. Int J Obstet Anesth. 2004;13:153–8.
87. Guignard B, Menigaux C, Dupont X, Fletcher D, Chauvin M. The effect of remifentanil on the bispectral index change and hemodynamic responses after orotracheal intubation. Anesth Analg. 2000;90:161–7.
88. Albertin A, Casati A, Federica L, Roberto V, Travaglini V, Bergonzi P, Torri G. The effect-site concentration of remifentanil blunting cardiovascular responses to tracheal intubation and skin incision during bispectral index-guided propofol anesthesia. Anesth Analg. 2005;101:125–30.
89. Goyagi T, Yoshimoto M. Comparison of hemodynamic responses associated with tracheal intubation under various induction doses of remifentanil and propofol. Open J Anesthesiol. 2012;2:154–60. doi:10.4236/ojanes.2012.24035.
90. Bouattour L, Ben Amar H, Bouali Y, Kolsi K, Gargouri A, Khemakhem K, Kallel N, Trabelsi K, Guermazi M, Rekik A, Karoui A. Maternal and neonatal effects of remifentanil for general anaesthesia for Caesarean delivery. Ann Fr Anesth Reanim. 2007;26:299–304 (Article in French).
91. Behdad S, Ayatollahi V, Harrazi H, Nazemian N, Heiranizadeh N, Baghianimoghadam B. Remifentanil at induction of general anesthesia for cesarean section: double blind, randomized clinical trial. Colomb Med (Cali). 2013;44:87–91.
92. Noskova P, Blaha J, Bakhouche H, Kubatova J, Ulrichova J, Marusicova P, Smisek J, Parizek A, Slanar O, Michalek P. Neonatal effect of remifentanil in general anaesthesia for caesarean section: a randomized trial. BMC Anesthesiol. 2015;15:38. doi:10.1186/s12871-015-0020-1.
93. Park BY, Jeong CW, Jang EA, Kim SJ, Jeong ST, Shin MH, Lee J, Yoo KY. Dose-related attenuation of cardiovascular responses to tracheal intubation by intravenous remifentanil bolus in severe pre-eclamptic patients undergoing Caesarean delivery. Br J Anaesth. 2011;106:82–7. doi:10.1093/bja/aeq275.
94. Yoo KY, Kang DH, Jeong H, Jeong CW, Choi YY, Lee J. A dose–response study of remifentanil for attenuation of the hypertensive response to laryngoscopy and tracheal intubation in severely preeclamptic women undergoing caesarean delivery under general anaesthesia. Int J Obstet Anesth. 2013;22:10–8. doi:10.1016/j.ijoa.2012.09.010.
95. Frassanito L, Vagnoni S, Zanfini BA, Catarci S, Maggiore S, Draisci G. General anesthesia for Caesarean delivery in a pregnant women affected by acute myocardial infarction. Eur Rev Med Pharmacol Sci. 2012;16(8):1123–6.
96. Miyawaki Y, Yumiba T, Asaga T, Taie S, Shirakami G. Remifentanil is useful for cardiovascular stability during cesarean delivery in a parturient with Marfan’s syndrome. Masui. 2010;59:1305–7 (in Japanese with English abstract).
97. Orme RMLE, Ainsworth QP, Grebenik CR. General anaesthesia using remifentanil for caesarean section in patients with critical aortic stenosis: a series or four cases. Int J Obstet Anesth. 2004;13:183–7.
98. Palacio FJ, Ortiz-Gómez JR, Fornet I, López MA, Morillas P. Remifentanil bolus for cesarean section in high-risk patients: study of 12 cases. Rev Esp Anestesiol Reanim. 2008;55:86–9 (in Spanish with English abstract).
99. Alexander R, Fardell S. Use of remifentanil for tracheal intubation for caesarean section in a patient with suxamethonium apnoea. Anaesthesia. 2005;60:1036–8.